Sinovac Biotech Stock News

KUALA LUMPUR: Pharmaniaga Bhd said early data from studies shows that the Sinovac vaccine booster shots are 94 per cent effective against the Omicron variant.

Millions Of Refugees Aren''t Getting Vaccines Because Drugmakers, NGOs Fear Lawsuits A global program designed to offer vaccines to tens of millions of migrants has been holding back on jabs because major manufacturers and the NGOs fear lawsuits over harmful side effects , according to Reuters , citing internal documents from Gavi - the charity operating the program. The legal concerns are an additional hurdle for public health officials tackling the coronavirus even as officials say unvaccinated people offer an ideal environment for it to mutate into new variants that threaten hard-won immunity around the world. Many COVID-19 vaccine manufacturers have required that countries indemnify them for any adverse events suffered by individuals as a result of the vaccines, the United Nations says. Where governments are not in control, that is not possible. -Reuters As a result, less than two million doses have been provided from a ''Humanitarian Buffer'' created by a global rogram known as COVAX, as the buffer has no mechanism to offer compensation.

In most Balkan countries, the situation with the spread of the coronavirus remains worrying. In some countries, the incidence is declining, but in others, the prevalence of coronavirus remains high. The new variant of COVID-19 Omicron, which has already been detected in seven countries - Turkey, Romania, Greece, Croatia, Slovenia, Montenegro, Cyprus - is of great concern. ALBANIA More than 300 new cases of COVID-19 have been registered in Albania in recent days. There are not many deaths in the country (several people a day). Since the beginning of the pandemic in Albania, nearly 205,000 cases of coronavirus infection have been registered and more than 3,150 people have died. To date, 2.22 million doses of COVID-19 vaccine have been administered in the country. 998 thousand people or 35 percent of the country''s population have been fully vaccinated. The vaccines of Pizer / Biontech, AstraZeneca, the Russian Sputnik V and the Chinese CoronaVac of the Sinovac company are allowed to be administered in Albania.

A new study found that two doses of Chinas Sinovac COVID-19 vaccine didnt generate appreciable numbers of antibodies against the new, highly infectious, omicron variant. The study tested the blood from 25 people who were fully vaccinated with Sinovacs Coronavac. None of them contain sufficient antibodies to neutralize the Omicron variant, researchers at the Department []

The latest study shows a third shot of Chinese biotech firm Sinovac''s inactivated vaccine can more than double the vaccine''s neutralizing antibody positive rate against the Omicron variant.

BEIJING: Pakistan International Airlines (PIA) has transported fresh consignments of 15 million doses of Sinovac Covid-19 vaccines by five special flights from the Capital International Airport Beijing to Islamabad, PIA Country Manager, Qadir Bux Sangi said on Wednesday. The national flag carrier launched special flights PAK-6852, PAK-6853, PK-6856, PK-6857 and PK-6858 respectively and airlifted fresh consignments of Sinovac vaccine from December 10 to December 15, he said. He informed that a PIA special flight PK-6858 carrying three million doses of Sinovac Covid-19 vaccines left the Chinese capital here for Islamabad. Last week, Pakistan Ambassador to China, Moin ul Haque had thanked China for standing by Pakistan during testing times, including the fight against COVID-19. The vaccine campaign which is going [on] in Pakistan, the 90 percent of it is being done through vaccines provided by China, he said. In a recent statement, a Chinese Foreign Ministry Spokesperson remarked that the China-Pakistan joint fight against Covid-19 pandemic had achieved a positive progress and set a good example for the world.

The market report delivers an all-inclusive analysis of the market structure along with a forecast of the various segments and sub-segments of the SARS-Cov-2 Vaccine (Vero Cell) industry. This wide-ranging market research report acts as a backbone for the success

None of the 25 people given a full course of CoronaVac had detectable levels of antibodies against Omicron, and boosters may be needed, researchers say.

The Covid-19 vaccine by Sinovac Biotech is not able to produce adequate antibodies to neutralise the highly mutated coronavirus strain Omicron, according to new research from the University of Hong Kong.Both the Sinovac vaccine and another by Pfizer-BioNTech produced inadequate antibody responses to the variant, scientists said in a statement Tuesday night.Of 25 people who received a full course of CoronaVac, none were found to have detectable levels of virus-fighting antibodies, according to

The results from a University of Hong Kong study will have a direct impact on countries like Cambodia which have heavily relied on Chinese supplied vaccines like Sinovac in vaccinating the populace. The post New report says that two doses of Sinovac vaccines are inadequate against Omicron virus variants appeared first on Khmer Times .

The initial lab findings may have sweeping consequences for the millions of people relying on the Chinese shot to protect them against Covid.

THE pharmaceutical company Pfizer said clinical trials showed that its Covid-19 vaccine is more than 90-percent effective for children aged 5 to 11 years old, according to Food and Drug Authority (FDA) Director General Dr. Rolando Enrique "Eric" Domingo. Pfizer submitted an emergency use application (EUA) to the FDA last week to administer its vaccine to the younger population group, and Domingo said the EUA is under review. He said a decision on the application could be made before the end of December. "What we saw from their clinical trial data is an efficacy of a little more than 90 percent, around 90.7 percent, for children 5 to 11 years old," Domingo said during a briefing on Monday. If the application is approved, the pediatric vaccine will have a lower dose and concentration. "Our primary concern is the safety before the efficacy, which our experts are thoroughly studying. So far, there are no very unusual or signal of very severe adverse effects based on the clinical trial — only mild," he said.

Sinovac vaccine is the only shot approved for children in Indonesia, and from next year the authorities would restrict its use only for this age group.

An additional 300,000 doses of Sinovac Covid-19 vaccine, provided by the Covax Facility, will arrive in this morning, said Ms. Youk Sambath, Secretary of State of the Ministry of Health. The post Cambodia set to receive 300,000 doses of Sinovac COVID-19 vaccine from Covax Facility appeared first on Khmer Times .